Making the grade - Pharmaceutical Representative
Pharmaceutical Representative March 2010 issue cover

Subscribe Now

Print subscribers
Get Online Access Here

Making the grade
How does pharma fit in with pay-for-performance?


Pharmaceutical Representative


Diagnosis
You've seen it before – but what does pay-for-performance really mean for you?

Prescription
Understanding incentives could change the way you do your job

If you've been through managed care training, you've probably had it up to here with the endless list of acronyms and abbreviations you need to contend with … but here's one more that's slowly working it's way into the sales professional's lexicon: P4P.



P4P is short for "pay-for-performance," a concept that was introduced several years ago and is now a commonly employed reimbursement strategy in both the commercial and government healthcare environments.

This article defines pay-for-performance, recaps its brief evolution, explains what's happening in today's market, and describes the potential ways it can impact the utilization (and hence, sales) of pharmaceutical and biotechnology products.

As you'll learn, the future may include performance-based reimbursement for your company's products – so the content that follows is well worth your attention.

What is pay-for-performance?

Definitions for pay-for-performance abound, but, essentially, P4P refers to a healthcare compensation program that features financially structured incentives for providers in exchange or as reward for the achievement of measurable performance benchmarks.


How one plan does it
Also known as "value-based purchasing" or "quality-based purchasing," the P4P payment model rewards physicians, hospitals, medical groups and other providers who meet specific performance standards for quality and efficiency. P4P programs typically feature some mix of incentives and/or disincentives. Incentives might include differential reimbursement rates or bonuses for meeting certain targets; commonly used disincentives include forfeited bonuses for exceeding targeted budgets or financial penalties for committing medical errors.

Regardless of their structure, the objective of pay-for-performance systems is to ensure the consistent delivery of high-quality, cost-effective care. The pay-for-performance approach assumes that financial rewards are strong motivators for managing behavior among providers.

Measurement criteria

Measurement criteria in pay-for-performance programs generally include some combination of the following factors:

  • Utilization and cost management (e.g., the number of emergency department visits per patient per year)
  • Clinical quality and effectiveness (e.g., the percentage of patients with asthma who are taking appropriate medications)
  • Patient satisfaction (e.g., the percentage of patients who would recommend the physician [or hospital, or clinic] to others),
  • Administrative capabilities (e.g., the organization's level of information technology)
  • Patient safety (e.g., the percentage of patients monitored for allergic drug reactions)

These and similar measures may be developed locally by a health plan or employer, or nationally, by recognized authorities such as the National Committee for Quality Assurance (NCQA).


ADVERTISEMENT

Source: Pharmaceutical Representative,
Click here